SEBI Reg. Investment Advisor

Download App
Help Center Pricing
Money Works 4 Me Logo MoneyWorks4Me
Login Get Free Account
Sign Up

MoneyWorks4Me

Log In Sign Up Schedule Free 15‑min Call
Login Get Free Account
Sign Up

INVESTMENT INSIGHTS

Check Before You Invest : Gujarat Themis Biosyn Ltd

BSE: 506879 NSE: GUJTHEM ISIN: INE942C01045
  |   Sector:  Healthcare   |   Industry:  Pharmaceuticals & Drugs

Snapshot

Q.1 Which industry/sub-sector does Gujarat Themis Biosyn Ltd belong to?
Gujarat Themis Biosyn Ltd belongs to the Healthcare sector, operating specifically within the Pharmaceuticals & Drugs segment.
Q.2 Is Gujarat Themis Biosyn Ltd a good quality company?
Gujarat Themis Biosyn Ltd is a good quality company, based on a consistently good 10 year financial track record.
Q.3 Is Gujarat Themis Biosyn Ltd undervalued or overvalued?
Gujarat Themis Biosyn Ltd appears Overvalued, as its key valuation ratios are above with their past averages.
Q.4 Is Gujarat Themis Biosyn Ltd a good buy now?
Gujarat Themis Biosyn Ltd is a neutral opportunity now, based on stable price trend analysis suggesting prices may move sideways. However, you need to check its quality and valuation before making a decision

Performance Analysis

Q.1 Revenue growth of Gujarat Themis Biosyn Ltd?
Gujarat Themis Biosyn Ltd revenue growth is -11.2% for FY-2025 , which is below its 5 year CAGR of 12.1% , indicating slower growth.
Q.2 Gross Profit margin of Gujarat Themis Biosyn Ltd?
Gujarat Themis Biosyn Ltd Gross profit margin which is the profit after deduction of direct costs, is 47% for FY-2025 , which is below its 5 year median of 48.8% , indicating decreasing margins.
Q.3 Operating Profit Margin of Gujarat Themis Biosyn Ltd?
Gujarat Themis Biosyn Ltd Operating Profit Margin which is the profit after deduction of all operating costs, is 45.65% for FY-2025 , which is below its 5 year median of 46.38% indicating decreasing margins.
Q.4 Net Profit Margin of Gujarat Themis Biosyn Ltd?
Gujarat Themis Biosyn Ltd Net Profit Margin is 32.34% for FY-2025 , is below with its 5 year median of 34.84%, indicating decreasing margins.
Current Level Historic Median
Gross Profit Margin 47 48.8
Operating Profit Margin 45.65 46.38
Net Profit Margin 32.34 34.84
Q.5 Return on Asset of Gujarat Themis Biosyn Ltd?
Gujarat Themis Biosyn Ltd Return on Asset is 17.44%, which is below its 5 year historical median of 35.65%, indicating deteriorated asset utilization efficiency.
Q.6 Return on Equity (ROE) of Gujarat Themis Biosyn Ltd?
Gujarat Themis Biosyn Ltd Return on equity is 21.69% for FY-2025 , which is below its historical median of 45.92%, indicating the business is making worse use of its shareholders capital.
Q.7 Return on capital employed (ROCE) of Gujarat Themis Biosyn Ltd?
Gujarat Themis Biosyn Ltd Return on capital employed is 27.48% for FY-2025 , which is above its estimated weighted average cost of capital(WACC) 14%, indicating value creation.
Q.8 Cash conversion cycle of Gujarat Themis Biosyn Ltd?
Gujarat Themis Biosyn Ltd Cash conversion cycle is 26 days, below its historical median of 47 days, indicating improved working capital management. However, you need to compare this with its peers in the industry.
Current Level Historic Median
Asset Turnover 0.54 0.92
ROE 21.69 45.92
ROCE 27.48 61.51
Cash Conversion Cycle 26 days 47 days
Q.9 Debt to Equity ratio of Gujarat Themis Biosyn Ltd?
Gujarat Themis Biosyn Ltd Debt-to-Equity ratio is 0.12 , which is lower with the industry average of 0.15 , indicating lower debt levels in the industry.
Q.10 Debt to cash flow from operations of Gujarat Themis Biosyn Ltd?
Gujarat Themis Biosyn Ltd Debt to cash flow from operations is 0.33 , which is at a healthy level.

Ownership & governance

Q.1 Promoter shareholding and pledge status of Gujarat Themis Biosyn Ltd?
Promoters hold 70.86% of the Gujarat Themis Biosyn Ltd, with 4.49% of their stake pledged, indicating low pledge risk.

Peer comparison (industry-wise, mcap)

Q.1 Revenue growth of Gujarat Themis Biosyn Ltd vs industry peers?
Gujarat Themis Biosyn Ltd revenue CAGR is 12.12% , compared to the industry median CAGR of 5.54% , indicating faster growth and gaining its market share.
Profit Metrics
Current Level Industry Median
Revenue 150.8 137.1
Gross Profit 71 15.1
Operating Profit 69 16
Net Profit 49 5.6
Operating Efficiency
Current Level Industry Median
Asset Turnover 0.54 0.8
ROE 21.69 8.91
ROCE 27.48 11.59
Cash Conversion Cycle (days) 26.24 76

Valuation & price assessment

Q.1 Stock return of Gujarat Themis Biosyn Ltd over the last decade?
Over the last 9 year(s), the stock has delivered a CAGR of 46.3% based on the current price.
Q.2 What return has the stock given over the last decade?
9Y 5Y 3Y 1Y
Share Price 46.3% 61.8% 48.5% -0.1%
Q.3 Valuation ratios of Gujarat Themis Biosyn Ltd vs historical?
The current P/E is higher that its historical median.
Q.4 How do the current valuation ratios measure up against the historic numbers and the current industry numbers?
Valuation Ratios Current Historic Median Industry Median
Price to Earnings 69.32 10.59 40.28
Price to Book 11.96 6.17 2.77
Price to Sales 20.79 3.31 2.65
EV to EBITDA 44.91 7.80 15.67

Check more companies

1. Ajanta Pharma
2. JB Chem & Pharma
3. Emcure Pharma
4. Gland Pharma
5. Wockhardt
6. Pfizer
7. Astrazeneca Pharma I
8. Sai Life Sciences
9. Natco Pharma
10. Eris Lifesciences
2026 ©The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me® is a registered trademark of The Alchemists Ark Pvt. Ltd.

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×